Christopher McCarthy
CFO & COO at Interpace Biosciences, Inc. (IDXG) since April 2023
Christopher McCarthy has filed 5 insider reports with the SEC since May 2023, as CFO & COO at Interpace Biosciences, Inc. (IDXG). The latest filing, on August 20, 2026, reports grant or award and exercise or conversion of a derivative at Interpace Biosciences, Inc. (IDXG).
- Filings
- 5
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Christopher McCarthy is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| CFO & COOsince April 2023 | 323,800 | Aug 20, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 20, 2026IDXGCFO & COO Mccarthy Christopher converted options into 277,009 shares, increasing direct ownership by 592% to 323,800 unitsForm 4Grant or awardExercise or conversion of a derivative
- Dec 1, 2024IDXGChief Financial Officer Mccarthy Christopher converted options into 38,475 shares, increasing direct ownership by 463% to 46,791 unitsForm 4Exercise or conversion of a derivative
- Feb 1, 2024IDXGMccarthy Christopher was granted 10,000 shares, increasing direct ownership by 28% to 45,644 unitsForm 4Grant or award
- Jul 31, 2023IDXGSEC Form 4: Mccarthy Christopher was granted 25,000 shares, increasing direct ownership by 235% to 35,644 unitsForm 4Grant or award
- Apr 21, 2023IDXGSEC Form 3: New insider Mccarthy Christopher claimed ownership of 7,310 sharesForm 3New insider
Compare Christopher McCarthy with
- Christopher McCarthy vs Vijay Aggarwal1 shared
- Christopher McCarthy vs Joseph D Keegan1 shared
- Christopher McCarthy vs Fortunato R. Rocca1 shared
- Christopher McCarthy vs Thomas John Freeburg1 shared
- Christopher McCarthy vs Peter Kamin1 shared
Other insiders at the same companies
- Thomas W. BurnellIDXG
- Vijay AggarwalIDXG
- Fortunato R. RoccaIDXG
- Joseph D KeeganIDXG
- Stephen J SullivanIDXG
- 1315 Capital II, L.P.IDXG
- Ampersand 2018 Limited PartnershipIDXG
Questions about Christopher McCarthy
- What is Christopher McCarthy's role at Interpace Biosciences, Inc.?
- Christopher McCarthy reports to the SEC as CFO & COO at Interpace Biosciences, Inc. (IDXG), according to the latest filing on August 20, 2026.
- How many shares does Christopher McCarthy own?
- After the latest filing that states it, Christopher McCarthy directly owned 323,800 shares of Interpace Biosciences, Inc. (IDXG). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Christopher McCarthy bought or sold stock recently?
- No open-market purchases or sales by Christopher McCarthy are on file. The filings report grant or award and exercise or conversion of a derivative.
- How do I get alerts when Christopher McCarthy files?
- Follow Christopher McCarthy on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Christopher McCarthy (SEC CIK 0001975031). Totals count each trade once, skipping amendments whose original is on file, from May 3, 2023 on. View on SEC EDGAR · Get this as JSON